Annexon, Inc.
ANNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001528115
In the last 90 days, Annexon, Inc. insiders filed 1 open-market purchase and 0 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.02B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Annexon, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 84 | 100 | +16 |
| Shares | 48.3M | 53.8M | +5.48M (+11.3%) |
| Value | $243.3M | $207.6M | −$35.7M (−14.7%) |
New holders (32)
Institutions that held Annexon, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (16)
Institutions that held Annexon, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| BVF Inc | 3,780,694 | $19.5M |
| Fairmount Funds Management LLC | 3,358,563 | $17.4M |
| Pura Vida Investments, LLC | 302,734 | $1.57M |
| Candriam Luxembourg S.C.A. | 164,558 | $850.7K |
| Gsa Capital Partners LLP | 161,360 | $834.0K |
| K2 Principal Fund, L.P. | 145,564 | $752.6K |
| Bank of Montreal | 65,380 | $365.0K |
| Invesco Ltd. | 50,263 | $259.9K |
| State of Wisconsin Investment Board | 26,800 | $138.6K |
| Balyasny Asset Management LLC | 21,605 | $111.7K |
| EWG Elevate Inc. | 15,000 | $77.5K |
| Mirabella Financial Services LLP | 11,836 | $61.2K |
| Belvedere Trading LLC | 8,301 | $42.9K |
| UBS Group AG | 4,100 | $21.2K |
| Freedom Wealth Alliance, LLC | 3,889 | $20.1K |
| Ellevest, Inc. | 405 | $2.09K |